Leaflet IVRYX 37.5mg prolonged release capsules


Indicated for: depression; anxiety disorders

Route of administration: oral

Substance: venlafaxine (serotonin-norepinephrine reuptake inhibitor)

ATC: N06AX16 (Nervous system | Antidepressants | Other antidepressants)

Precautions:
Driving impairment
Driving impairment

This medicine may affect your ability to drive or use machines.

Dizziness / vertigo
Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Breastfeeding warning
Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Suicidal ideation / mental changes
Suicidal ideation / mental changes

Seek medical help if suicidal thoughts or major behavior changes occur.

Withdrawal / do not stop abruptly
Withdrawal / do not stop abruptly

Do not stop treatment abruptly without medical advice.

Drowsiness / sedation
Drowsiness / sedation

This medicine may cause drowsiness or reduced alertness.

Venlafaxine is a medication used to treat major depressive disorder, generalized anxiety disorder, social anxiety disorder, and panic disorder. It belongs to the class of serotonin-norepinephrine reuptake inhibitors (SNRIs), working by increasing the levels of these neurotransmitters in the brain, which helps regulate mood and reduce anxiety symptoms.

Venlafaxine is usually taken once daily as extended-release tablets and can be taken with or without food. The dosage is gradually adjusted based on the patient's response and tolerance.

Common side effects include nausea, dizziness, dry mouth, insomnia, excessive sweating, and loss of appetite. In some cases, it may cause an increase in blood pressure, so regular monitoring is necessary.

It is important not to stop venlafaxine treatment abruptly, as this can lead to withdrawal symptoms such as irritability, dizziness, or sleep disturbances. Patients should strictly follow their doctor's recommendations and discuss any side effects or concerns.

General data about IVRYX 37.5mg

  • Substance: venlafaxine
  • Date of last drug list: 01-01-2014
  • Commercial code: W60226001
  • Concentration: 37.5mg
  • Pharmaceutical form: prolonged release capsules
  • Quantity: 28
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Pharmaceutical forms available for venlafaxine

Concentrations available for venlafaxine

  • 150mg
  • 25mg
  • 37.5mg
  • 50mg
  • 75mg